TherapeutAix will be attending the ERS International Congress in Paris from Sunday 16th to Wednesday 19th September. We would love to introduce our unique approach to project review, strategy and networked R&D, and discuss how we could help with your project. If you are interested, please get in touch via email@example.com and we will be happy to meet you.
We will be presenting posters with our network partner, Nordic BioSciences, describing our recent activities in developing translational assays and biomarkers to profile potential novel therapeutics for fibrotic lung diseases, including IPF. Please visit our posters on Sun 16th Sept1 and Wed 19th Sept2.
We look forward to seeing you in Paris!
- Scar-in-a-Jar, an in vitro screening tool for antifibrotics. PA597, Sunday 16th September.
- Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model. PA5255, Wednesday 19th September